Please login to the form below

Not currently logged in
Email:
Password:
PMLiVE Top Pharma List

19

Revenue 2017

Celgene

The Top Pharma List rankings are compiled from GlobalData's pharmaceutical revenue figures, which are based on prescription medicine sales, including generics drugs. They have been compiled below into an infographic of Celgene's 2013 oncology sales performance.

Celgene

NantKwest rockets on promising pancreatic cancer data

NantKwest rockets on promising pancreatic cancer data

Soon-Shiong made his initial fortune following the sale of two pharmaceutical companies which included Abraxis Bioscience, which was sold to Celgene back in  2010 for a meaty $2.9bn.

Driving the innovation engine

Driving the innovation engine By 1998, Celgene obtained FDA approval for its use in the treatment of leprosy. ... That year Celgene reported sales of $3.3m. Within two years the sales had grown to $62m.

New hires at Bristol-Myers Squibb, Acceleron and FerGene

New hires at Bristol-Myers Squibb, Acceleron and FerGene Acceleron . Acceleron Pharma has poached Jay Backstrom (pictured right) from Celgene, where he worked as chief medical officer. ... Prior to Celgene, he served as vice president, global medical affairs and safety at Pharmion.

GSK files anti-BCMA drug for myeloma after second trial win

GSK files anti-BCMA drug for myeloma after second trial win Patients in the trial had on average received seven earlier lines of therapy, including an immuno-modulatory drug such as Celgene’s Revlimid (lenalidomide), a proteasome inhibitor such as Takeda’s ... The followers include a CAR-T therapy from

Roche to close $4.3bn Spark deal after FTC clearance

Roche to close $4.3bn Spark deal after FTC clearance Roche is not the only big pharma who has faced pushback on a planned merger from the FTC – Bristol-Myers Squibb’s takeover of Celgene was delayed by an investigation and

1 2 3 4 5 6 7 8 9 10 [ Next 5 results ]

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Empowering Strategic Performance Ltd

OUR GOAL: To help clients Metamorph™ Science into Action that changes healthcare to improve the lives of patients. Empowering Strategic...

Latest intelligence

How do companies prepare for reimbursement?
Valid Insight explore how to optimise your market access strategy during new product development, how to address payer concerns and prepare for reimbursement....
EHR clinical trials
Integrating electronic health records into clinical trials
How organisations are working to realise the research potential of EHRs...
Mike Elliott Gilead
Keeping up the fight against HIV and using the lessons to tackle other threats
Danny Buckland interviews Gilead’s Mike Elliott...

Infographics